That in fact is the actual problem Lux " I would think that big pharma loves viruses more than anything else in the world as they can make endless money treating them for ever. " If we cure the virus it is only a one time payment . Still can't work out why a second or third tier pharma player never picked up BIT225 for Hep C . My maths suggest $100 mil for clinical 3 trials to share in $5 billion sales down the track . Makes sense to me !
Funding Structure, page-48
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 1.9¢ | $6.308K | 311.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1673695 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 93000 | 2 |
View Market Depth
| Last trade - 15.39pm 08/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |